Loading company…
Shengxin Medical develops cardiovascular devices for interventional heart failure treatment.
Shengxin Medical researches and develops cardiovascular interventional devices, including solutions based on balloon catheter and ECG collaboration technologies. Founded in 2022, the company is based in Suzhou, China, and raised Series A funding from Proxima Ventures in November 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in